Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53
- 2 December 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (51) , 7310-7318
- https://doi.org/10.1038/sj.onc.1203139
Abstract
Transcriptional activation by the tumor suppressor p53 is regulated at multiple levels, including posttranslational modifications of the p53 protein, interaction of p53 with various regulatory proteins, or at the level of sequence-specific DNA binding to the response elements in p53's target genes. We here propose as an additional regulatory mechanism that the DNA topology of p53-responsive promoters may determine the interaction of p53 with its target genes. We demonstrate that sequence-specific DNA binding (SSDB) and transcriptional activation by p53 of the mdm2 promoter is inhibited when this promoter is present in supercoiled DNA, where it forms a non-B-DNA structure which spans the p53-responsive elements. Relaxation of the supercoiled DNA in vitro resulted in conversion of the non-B-DNA to a B-DNA conformation within the mdm2 promoter, and correlated with an enhanced SSDB of p53 and an elevated expression of a reporter gene. In contrast, sequence specific DNA binding and transcriptional activation of the p21 promoter were not inhibited by DNA supercoiling. We propose that conformational alterations within p53-responsive sites, which either promote or prohibit sequence specific DNA binding of p53, are an important feature in orchestrating the activation of different p53 responsive promoters.Keywords
This publication has 30 references indexed in Scilit:
- Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loopOncogene, 1999
- Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assayOncogene, 1998
- The candidate tumour suppressor p33ING1cooperates with p53 in cell growth controlNature, 1998
- In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiationOncogene, 1997
- p53 expression in CMV‐infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2Histopathology, 1997
- Modulation of DNA Topoisomerase I Activity by p53Biochemistry, 1996
- p53 protein accumulation and gene mutations in human glioma cell linesInternational Journal of Cancer, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Regulation of the specific DNA binding function of p53Cell, 1992
- Slow cruciform transitions in palindromic DNA.Proceedings of the National Academy of Sciences, 1983